Exchange Announcement • 08 Oct 2026 21:09
Obi Forfeits The Subscription Of Obigen’S Cash Capital Increase, Distributes The Rights To Its Shareholders,And Sets The Target Date
Exchange Announcement • 05 Oct 2026 17:50
The Company’S Securities Have Reached The Standards For Announcement Of Trading Information
Exchange Announcement • 02 Oct 2026 14:37
Announcement Of Changes In The Company’S Financial Officer, Accounting Officer, And Corporate Governance Officer
Exchange Announcement • 10 Sep 2026 17:31
The Company’S Bod Approved To In-License Antibody Sequences From An U.S. University To Strengthen Obi’S Next-Generation Adc Pipeline
Exchange Announcement • 10 Sep 2026 17:31